Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor

Abroad (travel likely)Recruiting

Conditions

Axial Spondylarthritis (axSpA) · Psoriatic Arthritis (PsA)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Royal National Hospital for Rheumatic Diseases, Bath, Somerset, United Kingdom
Contact: Study coordinator (Clare Davey) · clare.davey1@nhs.net · 01225821800
Contact: Principal Investigator (Dr William Tillett)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy

Rheumatic Diseases · Rheumatoid Arthritis (RA) · Giant Cell Arteritis (GCA)

Abroad (travel likely)Recruiting

Bonn, Germany

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Moderate to Severe Plaque Psoriasis · Psoriatic Arthritis · Axial Spondyloarthritis

Abroad (travel likely)RecruitingPHASE1

Santa Monica, United States · South Miami, United States

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Psoriatic Arthritis · Axial Spondyloarthritis

Abroad (travel likely)RecruitingPHASE1

Peoria, United States · Apple Valley, United States

Rheumatology Patient Registry and Biorepository

Rheumatic Diseases · Adult Onset Still Disease · Ankylosing Spondylitis

Abroad (travel likely)Recruiting

New Haven, United States